Pacific Bio (PACB) Reports Q4 Revenues of $24.9 Million

Pacific Bio (NASDAQ: PACB) reported Q4 revenue of $24.9 million, versus $24.4 million reported last year.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Oracle (ORCL) Tops Q4 EPS by 16c, Offers Guidance
• Lands' End (LE) Tops Q1 EPS by 8c ; Offers Guidance